𝔖 Bobbio Scriptorium

✦ LIBER ✦

8508 Preliminary results of the randomized phase II TREMPLIN study: TPF Induction chemotherapy followed by radiotherapy plus cisplatin or cetuximab

✍ Scribed by Pointreau, Y.; Lefebvre, J.L.; Rolland, F.; Alfonsi, M.; Baudoux, A.; Sire, C.; de Raucourt, D.; Bardet, E.; Tuchais, C.; Calais, G.

Book ID: 122672138
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 66 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71599-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

583 Induction Chemotherapy with Docetaxe

583 Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study

✍ Perri, F.; Muto, P.; Schiavone, C.; Ionna, F.; Aversa, C.; Maiolino, P.; Cavalca 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT

✍ Alexandra D Jensen; Jürgen Krauss; Karin Potthoff; Almaz Desta; Gregor Habl; Ath 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 495 KB

8533 POSTER First Results of an Uncontro

8533 POSTER First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab+Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck

✍ Remenar, E.; Lövey, J.; Koltai, P.; Horvath, K.; Gödeny, M.; Kasler, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Cetuximab/Radiation Therapy (CET + RT) V

Cetuximab/Radiation Therapy (CET + RT) Versus Concomitant Chemoradiation Therapy (cCHT + RT) With or Without Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally Advanced Head-and-Neck Squamous Cell Carcinoma (LASCCHN) – Preliminary Results on Toxicity of a Randomized, 2x2 Factorial, Phase II-III Study (NCT01086826)

✍ Ghi, M.; Paccagnella, A.; Orecchia, R.; Parisi, S.; Bertoni, F.; Minguzzi, N.; B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

8546 POSTER A Phase II Study of Docetaxe

8546 POSTER A Phase II Study of Docetaxel, Cisplatin, and Oral S-1 Induction Chemotherapy Followed by Chemoradiotherapy in Advanced Squamous Cell Cancer of the Head and Neck – Preliminary Results: a Trial of the Korean South West Oncology Group

✍ Bae, W.; Kim, K.; Joo, Y.; Chung, I.; Cho, S.; Lee, K.; Song, E.; Yun, H.; Cho, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

O-040 Randomized phase III trial for sta

O-040 Randomized phase III trial for stage III unresectable nonsmall cell lung (NSCLC) cancer: Induction Chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)] followed by conventional radiation (RT) without (arm A) or with daily carboplatin (Cb) (arm B). Final results. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT

✍ Douillard, J.; Gervais, R.; Quoix, E.; Le Chevalier, T.; Le Groumellec, A.; Lema 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB